estrogen receptors

You have access
¹⁸F-Fluoroestradiol PET Imaging in a Phase II Trial of Vorinostat to Restore Endocrine Sensitivity in ER+/HER2− Metastatic Breast Cancer
Lanell M. Peterson, Brenda F. Kurland, Fengting Yan, Alena Novakova- Jiresova, Vijayakrishna K. Gadi, Jennifer M. Specht, Julie R. Gralow, Erin K. Schubert, Jeanne M. Link, Kenneth A. Krohn, Janet F. Eary, David A. Mankoff and Hannah M. Linden

Journal of Nuclear Medicine February 1, 2021, 62 (2) 184-190; DOI: https://doi.org/10.2967/jnumed.120.244459
You have access
In Vivo Quantification of ERβ Expression by Pharmacokinetic Modeling: Studies with ¹⁸F-FHNP PET
Inês F. Antunes, Antoon T.M. Willemsen, Jurgen W.A. Sijbesma, Ate S. Boerema, Aren van Waarde, Andor W.J.M. Glaudemans, Rudi A.J.O. Dierckx, Elisabeth G.E. de Vries, Geke A.P. Hospers and Erik F.J. de Vries

Journal of Nuclear Medicine November 1, 2017, 58 (11) 1743-1748; DOI: https://doi.org/10.2967/jnumed.117.192666
You have access
Synthesis and Evaluation of the Estrogen Receptor β–Selective Radioligand 2-¹⁸F-Fluoro-6-(6-Hydroxynaphthalen-2-yl)Pyridin-3-ol: Comparison with 16α-¹⁸F-Fluoro-17β-Estradiol
Inês F. Antunes, Aren van Waarde, Rudi A.J.O Dierckx, Elisabeth G.E. de Vries, Geke A.P. Hospers and Erik F.J. de Vries

Journal of Nuclear Medicine April 1, 2017, 58 (4) 554-559; DOI: https://doi.org/10.2967/jnumed.116.180158

Main menu